Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2014-08-29 06:51:15 UTC |
---|
Update Date | 2014-12-24 20:26:49 UTC |
---|
Accession Number | T3D4434 |
---|
Identification |
---|
Common Name | S-Sulfocysteine |
---|
Class | Small Molecule |
---|
Description | S-Sulfocysteine (SSC) is produced by reaction of inorganic sulfite and cystine by a yet unknown pathway and is a very potent NMDA-receptor agonist. Electrophysiological studies have shown that SSC displays depolarizing properties similar to glutamate. Patients affected with either Molybdenum cofactor deficiency (MOCOD, an autosomal recessive disease that leads to a combined deficiency of the enzymes sulphite oxidase, an enzyme that catalyzes the conversion of sulfite to inorganic sulfate, xanthine dehydrogenase and aldehyde oxidase) or isolated sulphite oxidase deficiency (ISOD, an extremely rare autosomal recessive disorder with identical clinical manifestations to MOCOD) excrete elevated levels of SSC. This rare disorder is associated with brain damage (seizures, spastic quadriplegia, and cerebral atrophy), mental retardation, dislocated ocular lenses, blindness, and excretion in the urine of abnormally large amounts of SSC, sulfite, and thiosulfate but no inorganic sulfate. (6, 7). |
---|
Compound Type | - Amine
- Animal Toxin
- Food Toxin
- Metabolite
- Natural Compound
- Organic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Synonym | Cysteine-S-sulfate | Cysteine-S-sulfonate | Cysteine-S-sulfonic acid | Cysteinyl-S-sulfonate | Cysteinyl-S-sulfonic acid | L-Cysteine S-sulfate | S-Sulfo-L-cysteine | S-Sulphocysteine |
|
---|
Chemical Formula | C3H6NO5S2 |
---|
Average Molecular Mass | 200.214 g/mol |
---|
Monoisotopic Mass | 199.969 g/mol |
---|
CAS Registry Number | 1637-71-4 |
---|
IUPAC Name | (2R)-2-amino-3-(sulfosulfanyl)propanoate |
---|
Traditional Name | S-sulfo-L-cysteinate |
---|
SMILES | [H][C@](N)(CSS(O)(=O)=O)C([O-])=O |
---|
InChI Identifier | InChI=1S/C3H7NO5S2/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)/p-1/t2-/m0/s1 |
---|
InChI Key | InChIKey=NOKPBJYHPHHWAN-REOHCLBHSA-M |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as s-sulfo-l-cysteines. These are s-conjugated L-cysteine where the S-substituent is specified as a sulfo group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | S-sulfo-L-cysteines |
---|
Alternative Parents | |
---|
Substituents | - S-sulfo-l-cysteine
- Alpha-amino acid
- L-alpha-amino acid
- S-alkyl thiosulfate
- Amino acid
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Sulfenyl compound
- Organic oxygen compound
- Amine
- Primary amine
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Primary aliphatic amine
- Carbonyl group
- Organopnictogen compound
- Hydrocarbon derivative
- Organic oxide
- Organic anion
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Endogenous |
---|
Cellular Locations | - Cytosol
- Extracellular
- Membrane
- Mitochondrion
- Plasma Membrane
- Synaptic Vesicle
|
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | |
---|
Pathways | Name | SMPDB Link | KEGG Link |
---|
Sulfur metabolism | Not Available | map00920 | Apoptosis | Not Available | map04210 | Glutathione biosynthesis | Not Available | Not Available |
|
---|
Applications | Not Available |
---|
Biological Roles | |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available | LogP | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0udi-1290000000-a605fed1bb7274e85c43 | 2016-08-01 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-00di-1900000000-639e8d434476b29e7cd2 | 2016-08-01 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0006-9200000000-a5114d144db3232e05ec | 2016-08-01 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0002-2900000000-37ede646876591d2cf08 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-00ds-9700000000-9e4da406118a2ae63d68 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-00e9-9200000000-f9620c023173424ca78b | 2016-08-03 | View Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | S-Sulfocysteine (SSC) is a very potent NMDA-receptor agonist. Electrophysiological studies have shown that SSC displays depolarizing properties similar to glutamate. Subcutaneous and intracerebral administration of SSC to infant rats induces brain damage. Apart from activating NMDA receptors, elevated SSC could also be neurotoxic by inhibition of the rate-limiting enzyme in glutathione synthesis (8), thereby reducing the intracellular levels of free radical scavengers. (6) |
---|
Metabolism | S-Sulfocysteine is produced by reaction of inorganic sulfite and cystine by a yet unknown pathway (6). Sulfite is generated via the catabolism of sulfur-containing amino acids cysteine and methionine (1). |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | S-Sulfocysteine is produced by reaction of inorganic sulfite and cystine by a yet unknown pathway (6). |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Neurotoxicity. |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB04370 |
---|
HMDB ID | HMDB00731 |
---|
PubChem Compound ID | 115015 |
---|
ChEMBL ID | Not Available |
---|
ChemSpider ID | Not Available |
---|
KEGG ID | C05824 |
---|
UniProt ID | Not Available |
---|
OMIM ID | |
---|
ChEBI ID | 27891 |
---|
BioCyc ID | Not Available |
---|
CTD ID | Not Available |
---|
Stitch ID | Not Available |
---|
PDB ID | Not Available |
---|
ACToR ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
References |
---|
Synthesis Reference | Pierre M. Bore, Jean-Claude Arnaud, “Keratin polymer containing S-sulphocysteine residues, process for its preparation and the compositions containing it.” U.S. Patent US4948876, issued May, 1981. |
---|
MSDS | Link |
---|
General References | - Belaidi AA, Schwarz G: Molybdenum cofactor deficiency: metabolic link between taurine and S-sulfocysteine. Adv Exp Med Biol. 2013;776:13-9. doi: 10.1007/978-1-4614-6093-0_2. [23392866 ]
- Graf WD, Oleinik OE, Jack RM, Weiss AH, Johnson JL: Ahomocysteinemia in molybdenum cofactor deficiency. Neurology. 1998 Sep;51(3):860-2. [9748040 ]
- Arnold GL, Greene CL, Stout JP, Goodman SI: Molybdenum cofactor deficiency. J Pediatr. 1993 Oct;123(4):595-8. [8410516 ]
- Duran M, Aarsen G, Fokkens RH, Nibbering NM, Cats BP, de Bree PK, Wadman SK: 2-Mercaptoethanesulfonate-cysteine disulfide excretion following the administration of 2-mercaptoethanesulfonate--a pitfall in the diagnosis of sulfite oxidase deficiency. Clin Chim Acta. 1981 Mar 19;111(1):47-53. [6784974 ]
- Beemer FA, Duran M, Wadman SK, Cats BP: Absence of hepatic molybdenum cofactor. An inborn error of metabolism associated with lens dislocation. Ophthalmic Paediatr Genet. 1985 Apr;5(3):191-5. [3877898 ]
- Abbas AK, Xia W, Tranberg M, Wigstrom H, Weber SG, Sandberg M: S-sulfo-cysteine is an endogenous amino acid in neonatal rat brain but an unlikely mediator of cysteine neurotoxicity. Neurochem Res. 2008 Feb;33(2):301-7. Epub 2007 Sep 1. [17764028 ]
- Rashed MS, Saadallah AA, Rahbeeni Z, Eyaid W, Seidahmed MZ, Al-Shahwan S, Salih MA, Osman ME, Al-Amoudi M, Al-Ahaidib L, Jacob M: Determination of urinary S-sulphocysteine, xanthine and hypoxanthine by liquid chromatography-electrospray tandem mass spectrometry. Biomed Chromatogr. 2005 Apr;19(3):223-30. [15558695 ]
- Moore W, Wiener HL, Meister A: Inactivation of gamma-glutamylcysteine synthetase, but not of glutamine synthetase, by S-sulfocysteine and S-sulfohomocysteine. J Biol Chem. 1987 Dec 15;262(35):16771-7. [2890640 ]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Not Available |
---|
Down-Regulated Genes | Not Available |
---|